Curated News
By: NewsRamp Editorial Staff
March 11, 2026

NeuroOne to Showcase OneRF Platform at Oppenheimer MedTech Conference

Discuss on LinkedIn Discuss on Telegram View History of this news story on GitHub
Original Source

TLDR

  • NeuroOne's participation in the Oppenheimer conference offers investors a chance to gain early insights into the OneRF platform's commercialization and pipeline milestones for competitive advantage.
  • NeuroOne's CEO and CFO will host virtual one-on-one meetings and deliver a presentation on March 17, 2026, detailing the OneRF platform's commercialization updates.
  • NeuroOne's technologies aim to improve patient outcomes for neurological disorders by reducing hospitalizations and surgical procedures, potentially making healthcare more effective and accessible.
  • NeuroOne's OneRF platform combines diagnostic and therapeutic functions for brain treatment, pain management, and advanced drug delivery in a minimally invasive electrode system.

Impact - Why it Matters

This news matters because NeuroOne's participation in a major healthcare investment conference highlights the growing importance of innovative neurological treatments. The company's OneRF platform and other FDA-cleared technologies represent significant advancements in minimally invasive brain surgery and pain management, potentially reducing hospital stays and improving patient outcomes. For investors, this signals NeuroOne's strategic efforts to secure funding and partnerships to scale its solutions, which could accelerate access to better neurological care. For patients and healthcare providers, it underscores progress toward more effective, cost-efficient treatments for conditions like epilepsy, chronic pain, and other neurological disorders, addressing a critical need in global healthcare.

Summary

NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a pioneering medical technology company dedicated to transforming neurological disorder treatments, has announced its participation in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference. The virtual event, scheduled for March 17, 2026, will feature key executives including President & CEO Dave Rosa and CFO Ron McClurg, who will host one-on-one meetings with institutional investors. Rosa is also slated to deliver a company presentation at 1:20 p.m. Eastern Time in Track 1, where he will provide crucial commercialization updates and pipeline milestones for the innovative OneRF® platform, which targets brain treatment, pain management, and advanced drug delivery.

The conference represents a significant opportunity for NeuroOne to showcase its FDA-cleared technologies to the investment community. The company's portfolio includes four distinct product families: Evo® Cortical Electrodes, Evo® sEEG Electrodes, OneRF® Ablation System for brain applications, and the OneRF® Trigeminal Nerve Ablation System. These minimally invasive, high-definition electrode technologies aim to reduce hospitalizations, lower healthcare costs, and improve patient outcomes by combining diagnostic and therapeutic functions. For those interested in attending, the webcast link is available Here, and additional conference details can be found on the conference website Here, with scheduling requests directed to NMTC@mzgroup.us.

NeuroOne's broader mission focuses on enhancing surgical care for neurological disorders through advanced medical technology. Beyond its current offerings, the company is actively engaged in research and development for drug delivery and spinal cord stimulation programs, positioning itself at the forefront of neurological innovation. Investors and stakeholders can learn more about the company's initiatives by visiting nmtc1.com, where comprehensive information about its technologies and impact is available. This participation in the Oppenheimer conference underscores NeuroOne's commitment to advancing neurological healthcare and engaging with the financial community to support its growth trajectory.

Source Statement

This curated news summary relied on content disributed by NewMediaWire. Read the original source here, NeuroOne to Showcase OneRF Platform at Oppenheimer MedTech Conference

blockchain registration record for this content.